Understanding Graham Little-Piccardi-Lassueur Syndrome

Receiving a diagnosis of Graham Little-Piccardi-Lassueur Syndrome (GLPLS) can feel overwhelming, especially given its rarity. It is natural to feel a mix of fear regarding the changes to your body and relief at finally having an answer for a complex set of symptoms. While the name is a mouthful, understanding the mechanics of the condition is the first step toward regaining a sense of control.

GLPLS is a rare variant of Lichen Planopilaris (LPP), an inflammatory condition where your immune system mistakenly attacks your hair follicles ^[1][2]. It primarily affects women between the ages of 40 and 60 ^[1][3]. Although it is rare enough that specific incidence rates are hard to pinpoint, it is well-documented in medical literature as a specific “triad” of symptoms.

The Classic Triad

Doctors identify GLPLS by looking for three specific signs that occur together:

1. Cicatricial Alopecia of the Scalp: This is scarring hair loss that occurs in patches. Because the immune system attacks the stem cells of the hair follicle, the hair cannot grow back once the follicle has been replaced by scar tissue ^[1][4].
2. Non-Cicatricial Alopecia: You may notice thinning or loss of hair in the armpits or the pubic area. Unlike the scalp, this hair loss is typically non-scarring, meaning the follicles themselves are not necessarily destroyed ^[1][5].
3. Follicular Keratosis: These are small, rough, red or skin-colored bumps that feel like sandpaper. They usually appear on the trunk, arms, or legs ^[5][3].

Three Facts to Steady Your Focus

• Treatment is about protection. While we cannot currently reverse the scarring on the scalp, the primary goal of treatment is to “freeze” the condition in its tracks ^[4]. By calming the immune response, your care team works to protect the hair you currently have.
• The body hair loss is different. It can be reassuring to know that the hair loss in your armpits and groin does not follow the same permanent scarring path as the scalp hair loss ^[1]. However, even though the follicles are spared from scarring, regrowth in these areas is unpredictable. Some patients see hair return once inflammation is controlled, while for others, the follicles remain dormant and hairless.
• Research is advancing. Because GLPLS is driven by specific inflammatory pathways in the immune system, researchers are testing new, targeted therapies. JAK inhibitors and other modern medications are showing promise in managing cases that don’t respond to traditional treatments ^[6][7].

What Science Knows (and is Still Learning)

Medical consensus agrees that GLPLS is an autoimmune-mediated process ^[2]. Your body’s T-cells—the “soldiers” of the immune system—recruit inflammatory proteins like interferon-gamma to mistakenly attack the hair follicle ^[8].

What remains uncertain is the exact “trigger” that starts this process. Researchers are investigating whether it is sparked by specific medications, environmental factors, or a genetic predisposition ^[9][10]. Because it is so rare, there is no single “gold standard” cure, so treatment is often tailored to the individual, using a combination of topical steroids, oral medications, or even light therapy ^[11][12]. The focus of your medical journey will be to find the specific combination that halts the inflammation for you.

Return to Home Page